LakeShore Biopharma Co Net Income

LakeShore Biopharma Co (LSB) currently reports a net income of $-210M as of March 2024. That compares with $6.9M in the prior-year period — down 3182.5% year over year. That is below the sector sector average of $130M. Use the charts on this page to explore LakeShore Biopharma Co's net income history and peer comparisons.

LakeShore Biopharma Co's net income decreased from $6.9M to $-210M — a 3182.5% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co's net income of $-210M is lower than the its sector sector average of $130M. That is roughly 261.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

LakeShore Biopharma Co reported $-210M in net income as of March 2024. That compares with $6.9M in the prior-year period — down 3182.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-210M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $130M. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following LSB for alerts when major investors trade the stock.